openPR Logo
Press release

Non-alcoholic Steatohepatitis (NASH) Biomarkers Market to Cross US$1.7 bn by 2024

11-22-2017 10:14 AM CET | Health & Medicine

Press release from: Transparency Market Research

Non-alcoholic Steatohepatitis (NASH) Biomarkers Market

Some of the leading players operating in the global non-alcoholic steatohepatitis (NASH) biomarkers market are One Way Liver S.L., Siemens Healthineers, Genfit, and SNIBE Diagnostics, observes Transparency Market Research. The majority of the players in the market are focusing on conducting clinical trials to introduce improved biomarkers that deliver accurate results. Companies are also expected to expand their distribution channels through strategic collaborations in the coming years.

According to the research report, the global NASH biomarkers market is expected to reach a valuation of US$1.7 bn by the end of 2024 as compared to US$201.2 mn in 2016. Between the forecast period of 2016 and 2024, the global market is projected to expand at a CAGR of 31.7%.

On the basis of type, the global market is segmented into serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers, and others. Out of these, the hepatic fibrosis biomarkers segment is expected to progress at a phenomenal CAGR of 32.7% between 2016 and 2024. The growth of this segment will be attributable to the high accuracy and efficacy provided by these biomarkers.

Read Report Overview @ https://www.transparencymarketresearch.com/non-alcoholic-steatohepatitis-biomarkers-market.html

In terms of geography, the overall market is fragmented into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. The report predicts that North America is likely to hold a significant share in the overall market in the coming years due to the emergence of NASH health care sector. However, Europe is expected to dominate the global market as it is estimated to progress at a CAGR of 30.80% between 2016 and 2024.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18650

Preference for Non-invasive Procedures Contributes to Soaring NASH Biomarkers Market Revenue

The rising prevalence of non-alcoholic liver diseases has been the primary growth driver for the NASH biomarkers market. The growing number type 2 diabetics are estimated to boost the overall market as this pool is population is prone to NAFLAD along with other liver diseases. The market is also anticipated to be driven by the changing lifestyles that are characterized by smoking, poor eating habits, and lack of exercise. The smothering rise in air pollution is also expected to drive the global NASH biomarkers market in the coming years.

Request Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18650

The growing demand for non-invasive diagnostic techniques to determine the complication and stage of the liver diseases have also augmented the demand for NASH biomarkers. Due to the ability of reproduce the results, these biomarkers have become the preferred choice for diagnosing and monitoring NASH. The market is also slated to find an adequate drive in treating the unmet medical needs of NASH as the liver-related diseases are on the rise. Demand for low-cost diagnostic techniques as compared to liver biopsy, which requires hospital stay and anesthesia are also likely to encourage the growth of the global market.

Lack of Accuracy of Individual Biomarkers Restrains Market Growth

The limitations pertaining to the accuracy and sensitivity in determining the results in the key challenge for the players operating in the global NASH biomarkers market. Thus, the questionable accuracy of individual biomarkers and their panels is anticipated to restrain the growth of the overall market. Furthermore, the global NASH biomarkers market is also challenged by the overlapping results for other metabolic disorders. Since these biomarkers deliver overlapping results for metabolic diseases such as glycogenic hepatopathy, diabetic hepatosclerosis, and Wilson diseases the reliability of the biomarkers remains under question.

Buy Full Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=2170<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact

Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
TMR Blog: http://www.theglobalhealthnews.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-alcoholic Steatohepatitis (NASH) Biomarkers Market to Cross US$1.7 bn by 2024 here

News-ID: 827850 • Views:

More Releases from Transparency Market Research

RF Chip Inductor Market Size to Reach over USD 1.8 billion by 2031 - Transparency Market Research Inc.
RF Chip Inductor Market Size to Reach over USD 1.8 billion by 2031 - Transparenc …
RF Chip Inductor Market are essential components in various electronic devices, providing inductance and functioning as filters, oscillators, and transformers. They play a crucial role in ensuring the efficiency and performance of RF circuits. With the rapid advancement in telecommunications, consumer electronics, and automotive industries, the demand for RF chip inductors has seen a significant rise. These components are integral in applications such as smartphones, IoT devices, and automotive electronics,
Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
The latest research study released by Transparency Market Research on "Solid Tires Market Forecast to 2023-2031 ″ research provides accurate economic, global, and country-level predictions and analyses. Solid Tires market is estimated to attain a valuation of US$ 760.0 Mn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 8.1% during
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031| Says Transparency Market Research
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031 …
The latest research study released by Transparency Market Research on "𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐂𝐲𝐛𝐞𝐫 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Automotive Cyber security industry, as
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from 2022 to 2031: TMR Study
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from …
The latest research study released by Transparency Market Research on "𝐑𝐞𝐚𝐝𝐲-𝐦𝐢𝐱 𝐂𝐨𝐧𝐜𝐫𝐞𝐭𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Ready-mix Concrete industry, as well as

All 5 Releases


More Releases for NASH

Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date. The NASH
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance. NASH
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028 The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining
NASH Market Insight and Landscape report
Report Snapshot: NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their
04-07-2017 | Arts & Culture
Memphia PR
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017. Listening to the Beatles and Jack White growing
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will